The neuropsychiatry of adult-onset adrenoleukodystrophy

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 11, Issue 3, 1999, Pages 315-327

  Rosebush, Patricia I ^a,b   Garside, Sarah ^a   Levinson, Anthony J ^a   Mazurek, Michael F ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b Department of Psychiatry   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; LITHIUM; OLANZAPINE; RISPERIDONE; VERY LONG CHAIN FATTY ACID;

ADRENAL CORTEX; ADRENOLEUKODYSTROPHY; BLOOD ANALYSIS; BRAIN; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DISORDERS OF PEROXISOMAL FUNCTIONS; EXTRAPYRAMIDAL SYMPTOM; GENETIC COUNSELING; HUMAN; HYPOALDOSTERONISM; MANIA; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; TESTIS; X CHROMOSOME LINKAGE;

EID: 0032868610     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.11.3.315     Document Type: Review

References (98)

1. Moser HW, Moser A: Adrenoleukodystrophy, in The Metabolic and Molecular Basis of Inherited Diseases, edited by Scriver CR, Beaudet AL, Sly WS, et al. New York, McGraw-Hill, 1995
2. Moser HW: Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997; 120:1485-1508
3. Moser HW, Moser AE, Singh I, et al: Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol 1984; 16:628-641
4. Moser HW, Moser AB, Naidu S, et al: Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 1991; 13:254-264
5. Schaumburg HH, Powers JM, Raine CS, et al: Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol 1975; 32:577-591
6. Van Geel BM, Assies J, Wanders JA, et al: X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry 1997; 63:4-14
7. Griffin JW, Goren E, Schaumburg H, et al: Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy, I: clinical and endocrinologic aspects. Neurology 1977; 27:1107-1113
8. Kitchen W, Cohen-Cole SA, Mickel SF: Adrenoleukodystrophy: frequency of presentation as a psychiatric disorder. Biol Psychiatry 1987; 22:1375-1387
9. Gray AM: Addison's disease and diffuse cerebral sclerosis. J Neurol Neurosurg Psychiatry 1964; 32:344-347
10. James ACD, Kaplan P, Lees A, et al: Schizophreniform psychosis and adrenomyeloneuropathy. J R Soc Med 1984; 77:882-884
11. Sereni C, Ruel M, Iba-zizen T, et al: Adult adrenoleukodystrophy: a sporadic case? J Neurol Sci 1987; 80:121-128
12. Panegyres PK, Goldswain P, Kakulas BA: Adult-onset adrenoleukodystrophy manifesting as dementia. Am J Med 1989; 87:481-483
13. Weller M, Liedtke W, Peterson D, et al: Very-late-onset adrenoleukodystrophy: possible precipitation of demyelination by cerebral contusion. Neurology 1992; 42:367-370
14. Angus B, de Silva R, Davidson R, et al: A family with adult-onset cerebral adrenoleucodystrophy. J Neurol 1994; 241:497-499
15. Sobie G, Ueno-Natsukari I, Okamoto H, et al: Phenotypic heterogeneity of an adult form of adrenoleukodystrophy in monozygotic twins. Ann Neurol 1994; 36:912-915
16. Menza MA, Blake J, Goldberg L: Affective symptoms and adrenoleukodystrophy: a report of two cases. Psychosomatics 1988; 29:442-445
17. Aubourg P, Mosser J, Douar AM, et al: Adrenoleukodystrophy gene: unexpected homology to a protein involved in peroxisome biogenesis. Biochimie 1993; 75:293-302
18. Mosser J, Lutz Y, Stoeckel ME, et al: The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994; 3:265-271
19. Higgins CF: ABC transporters: from microorganisms to man. Ann Rev Cell Biol 1992; 8:67-113
20. Kok F, Neumann S, Sarde CO, et al: Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum Mutat 1995; 6:104-115
21. Marsden CD, Obeso JA, Lang AE: Adrenoleukomyeloneuropathy presenting as spinocerebellar degeneration. Neurology 1992; 32:1031-1032
22. Migeon BR, Moser HW, Moser AB, et al: Adrenoleukodystrophy: evidence for X-linkage, inactivation and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci USA 1996; 78:5066-5070
23. Puck JM, Willard HF: X-inactivation in females with X-linked disease. N Engl J Med 1998; 338:325-327
24. Powers JM, Moser HW: Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions and pathogenesis. Brain Pathol 1998; 8:101-120
25. Powers JM: The pathology of peroxisomal disorders with pathogenetic considerations. J Neuropathol Exp Neurol 1995; 54:710-719
26. Cartier N, Lopez J, Moullier P, et al: Retroviral-mediated gene transfer corrects very long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci USA 1995; 92:1674-1678
27. Moser HW: Pathogenetic mechanisms in peroxisomal disorders. Curr Opin Neurol 1996; 9:473-477
28. Tsuji S, Sano T, Ariga T, et al: Increased synthesis of hexacosanoic acid (C23:0) by cultured fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem 1981; 90:1233-1236
29. Wilson R, Tocher DR, Sargent JR: Effects of exogenous mono-unsaturated fatty acids on fatty acid metabolism in cultured skin fibroblasts from adrenoleukodystrophy patients. J Neurol Sci 1992; 109:207-214
30. Ho JK, Moser H, Kishimoto Y, et al: Interactions of a very long chain fatty acid with model membranes and serum albumin: implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 1995; 96:1455-1463
31. Whitcomb RW, Linehan WM, Knazek RA: Effects of long-chain fatty acids on membrane microviscosity and adrenocorticotropin responsiveness in human adrenocortical cells in vitro. J Clin Invest 1988; 81:185-188
32. Powers JM, Liu Y, Moser AB, et al: The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules and pathogenetic implications. J Neuropathol Exp Neurol 1992; 51:630-643
33. McGuinness MC, Powers JM, Bias WB, et al: Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol 1997; 75:174-182
34. Erlington GM, Bateman DE, Jeffrey MJ, et al: Adrenoleukodystrophy: heterogeneity in two brothers. J Neurol Neurosurg Psychiatry 1989; 52:310-313
35. Simpson RHW, Rodda J, Reinecke CJ: Adrenoleukodystrophy in a mother and son. J Neurol Neurosurg Psychiatry 1987; 50:1165-1172
36. Weiss GM, Nelson RL, O'Neill BP, et al: Use of adrenal biopsy in diagnosing adrenomyeloneuropathy. Arch Neurol 1980; 37:634-036
37. Ladenson PW: Adrenoleukodystrophy. JAMA 1989; 262:1504-1506
38. Kuroda S, Hirano A, Yuasa S: Adrenoleukodystrophy-cerebello-brainstem dominant case. Acta Neuropathol 1983; 60:149-152
39. Jeffcoate WJ, McGivern D, Cotton RE, et al: Late-onset adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 1987; 50:1238-1239
40. Scully RE, Galdabini JJ, McNeely BU: Case 18-1979: Case records of the Massachusetts General Hospital. N Engl J Med 1979; 300:1037-1045
41. Probst A, Ulrich J, Heitz U, et al: Adrenomyeloneuropathy: a protracted pseudosystemic variant of adrenoleukodystrophy. Acta Neuropathol 1972; 49:105-115
42. Davis LE, Snyder RD, Orth DN, et al: Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred. Am J Med 1979; 66:342-347
43. Peckham RS, Marshall MC, Rosman PM, et al: A variant of adrenomyeloneuropathy with hypothalamic-pituitary dysfunction and neurologic remission after glucocorticoid replacement therapy. Am J Med 1982; 72:173-176
44. Ohno T, Tsuchiya H, Fukuhara N, et al: Adrenoleukodystrophy: new clinical variant presenting as olivopontocerebellar atrophy. Ann Neurol 1983; 14:148-149
45. Budka H, Sluga E, Heiss WD: Spastic paraplegia associated with Addison's disease: adult variant of adreno-leukodystrophy. J Neurol 1976; 213:237-250
46. O'Neill BP, Marmion LC, Feringa ER: The adrenoleukomyeloneuropathy complex: expression in four generations. Neurology 1981; 31:151-156
47. Maris T, Androulidakis EJ, Tzagournissakis M, et al: X-linked adrenoleukodystrophy presenting as neurologically pure familial spastic paraparesis. Neurology 1994; 45:1101-1104.
48. Crum BA, Carter JL: 26 year old man with hyperpigmentation of skin and lower extremity spasticity. Mayo Clin Proc 1997; 72:479-482
49. Munchau A, Hagel C, Vogel P: Adrenoleukodystrophy of very late onset. J Neurol 1997; 244:595-599
50. Schwankhaus JD, Katz DA, Eldridge R, et al: Clinical and pathological features of an autosomal dominant, adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. Arch Neurol 1994; 51:757-766
51. Dodd A, Rowland SA, Hawks SL, et al: Mutations in the adrenoleukodystrophy gene. Hum Mutat 1997; 9:500-511
52. Garside S, Rosebush PI, Levinson AJ, et al: Late-onset adrenoleukodystrophy associated with long-standing psychiatric symptoms. J Clin Psychiatry 1999 (in press)
53. Dooley JM, Wright BA: Adrenoleukodystrophy mimicking multiple sclerosis. J Can Neurol Sci 1985; 12:73-74
54. El-Deiry SS, Naidu S, Blevins LS, et al: Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J Clin Endocrinol Metab 1997; 82:856-860
55. Restuccia D, DiLassaro V, Valeriani M, et al: Neurophysiological abnormalities in adrenoleukodystrophy carriers: evidence of different degrees of central nervous system involvement. Brain 1997; 120:1139-1148
56. Aubourg P, Chaussain JL: Adrenoleukodystrophy presenting as Addison's disease in children and adults. Trends in Endocrinology and Metabolism 1991; 2:49-52
57. Blevins LS Jr, Shankroff J, Moser HW, et al: Elevated plasma adrenocorticotropin concentration as evidence of limited adrenocortical reserve in patients with adrenomyeloneuropathy. J Clin Endocrinol Metab 1994; 78:261-265
58. Korenke GC, Roth C: Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleukodystrophy: clinical, laboratory and genetic findings. Eur J Endocrinol 1997; 137:40-47
59. Brenneman W, Kohler W, Zierz S, et al: Testicular dysfunction in adrenomyeloneuropathy. Eur J Endocrinol 1997; 137: 34-39
60. Afifi AK, Menezes AH, Reed LA, et al: Atypical presentation of X-linked adrenoleukodystrophy with an unusual magnetic resonance imaging pattern. J Child Neurol 1996; 11:497-499
61. Castellote A, Vera J, Vasquez E, et al: MR in adrenoleukodystrophy: atypical presentation as bilateral frontal demyelination. Am J Neuroradiology 1995; 16 suppl 4:814-815
62. Close PJ, Sinnott SJ, Nolan KT: Adrenoleukodystrophy: a case report demonstrating unilateral abnormalities. Pediatr Neuroradiol 1995; 37:568-775
63. MacDonald JT, Stauffer AE, Heitoff K: Adrenoleukodystrophy: early frontal lobe involvement on computed tomography. J Comput Assist Tomogr 1984; 8:128-130
64. Young RS, Ramer JC, Towfighi J, et al: Adrenoleukodystrophy, unusual computed tomographic appearance. Arch Neurol 1982; 39:782-783
65. Farrell DF, Hamilton SR, Krauss TA, et al: X-linked adrenoleukodystrophy: adult cerebral variant. Neurology 1993; 43:1518-1522
66. Korenke GC, Fuchs S, Krasemann E, et al: Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol 1996; 40:254-257
67. Chatterjee A, Yapundich R, Palmer CA, et al: Leukoencephalopathy associated with cobalamin deficiency. Neurology 1996; 46:832-834
68. Lee TG, Solomon GD, Kunkel RS, et al: Late-presenting metachromatic leukodystrophy. Lancet 1996; 348:1382-1384
69. Wiebe S, Lee DH, Karlik SJ, et al: Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992; 32;643-650
70. Kapoor R, Crockard A, Moseley IF: Clinical onset and MRI features of Krabbe's disease in adolescence. J Neurol Neurosurg Psychiatry 1992; 55:331-332
71. Filley CM, Heaton RK, Rosenberg NL: White matter dementia in chronic toluene abuse. Neurology 1990; 40:532-534
72. Triulzi F, Scotti G: Differential diagnosis of multiple sclerosis: contribution of magnetic resonance techniques. J Neurol Neurosurg Psychiatry 1998; 64(suppl 1):S6-14
73. Lindenbaum J, Healton EB, Savage DG, et al: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318:1720-1728
74. Hyde TM, Ziegler JC, Weinberger DR: Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis. Arch Neurol 1992; 49:401-406
75. Waldman AJ: Sometimes when you hear hoofbeats . . . : two cases of inherited metabolic diseases with initial presentation of psychiatric symptoms (letter). J Neuropsychiatry Clin Neurosci 1992; 4:113-114
76. Mahon-Haft H, Stone RK, Johnson R, et al: Biochemical abnormalities of metachromatic leukodystrophy in an adult psychiatric population. Am J Psychiatry 1981; 138:1372-1374
77. Arias Bal A, Vazquez-Barquero JL, Pena C, et al: Psychiatric aspects of multiple sclerosis. Acta Psychiatr Scand 1991; 83:292-296
78. Rodgers J, Bland R: Psychiatric manifestations of multiple sclerosis: a review. Can J Psychiatry 1996; 41:441-445
79. Thomeer EC, Verhoeven WM, van de Vlasakker CJ, et al: Psychiatric symptoms in MELAS; a case report. J Neurol Neurosurg Psychiatry 1998; 351:692-693
80. Moloney JBM, Masterson JG: Detection of adrenoleukodystrophy carriers by means of evoked potentials. Lancet 1982; ii:852-853
81. Garg BP, Markland OK, DeMyer WE, et al: Evoked response studies in patients with adrenoleukodystrophy and heterozygous carriers. Arch Neurol 1983; 40:356-359
82. Moser HW: Adrenoleukodystrophy: natural history, treatment and outcome. J Inherit Metab Dis 1995; 18:435-447
83. Aubourg P, Adamsbaum C, Larallard-Rousseau MC, et al: A two year trial of oleic and erucic acids (Lorenzo's oil) as treatment for adrenomyeloneuropathy. N Engl J Med 1993; 329:745-752
84. Rizzo WB: Lorenzo's oil: hope and disappointment (editorial). N Engl J Med 1993; 329:801-802
85. Korenke GC, Hunneman DH, Kohler J, et al: Glyceroltrioleate/ glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters. Eur J Pediatr 1996; 154:64-70
86. Aubourg P, Blanche S, Jambaque, et al: Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplant. N Engl J Med 1990; 322:1860-1866
87. Krivit W, Lockman LA, Watkins PA, et al: The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic lettkodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 1995; 18:398-412
88. Loes DJ, Stillman AE, Hite S, et al: Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations. Am J Neuroradiol 1994; 15:1767-1771
89. MacQueen GM, Rosebush PI, Mazurek MF: Neuropsychiatric aspects of the adult-onset variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 1998; 10:10-19
90. Rosebush PI, MacQueen GM, CIarke JTR, et al: Late-onset Tay Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry 1995; 56:347-353
91. Maurer I, Moller HJ: Inhibition of complex 1 by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem 1997; 174:255-259
92. Burkhardt C, Kelly JP, Lim YH, et al: Neuroleptic medications inhibit complex 1 of the electron transport chain. Ann Neurol 1993; 33:512-517
93. Rosebush PI, Mazurek MF: Neurological side-effects of risperidone. Neurology 1999; 52:782-785
94. Ford B, Lynch T, Greene P: Risperidone in Parkinson's disease (letter). Lancet 1994; 344:681
95. Rich SS, Friedman JH, Ott BR: Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J Clin Psychiatry 1995; 56:556-559
96. Beasley CM: Safety of olanzapine. J Clin Psychiatry monograph series 1997; 15:19-21
97. Marder SR: Adverse effects of clozapine. J Clin Psychiatry monograph series 1996; 14:11-12
98. Devinsky O, Honigfeld G, Patin J: Clozapine-related seizures. Neurology 1991; 41:369-371